SEGLUROMET 2.5 MG / 850 MG FILM-COATED TABLETS - patient leaflet, side effects, dosage

Patient leaflet - SEGLUROMET 2.5 MG / 850 MG FILM-COATED TABLETS

Package leaflet: Information for the patient

Segluromet

if you get any side effects, talk to your doctor, pharmacist, or nurse. this includes any possible side effects not listed in this leaflet. see section 4.

What is in this leaflet

1. What Segluromet is and what it is used for
2. What you need to know before you take Segluromet
3. How to take Segluromet
4. Possible side effects
5. How to store Segluromet
6. Contents of the pack and other information

1. what segluromet is and what it is used for

What Segluromet is

Segluromet contains two active substances, ertugliflozin and metformin.

Ertugliflozin belongs to a group of medicines called sodium glucose co-transporter-2 (SGLT2) inhibitors.
Metformin belongs to a group of medicines called biguanides.

What Segluromet is used for

Segluromet lowers blood sugar levels in adult patients (aged 18 years and older) with type 2 diabetes.
Segluromet can be used instead of taking both ertugliflozin and metformin as separate tablets.
Segluromet can be used alone or with some other medicines that lower blood sugar.
You need to keep following your food and exercise plan while taking Segluromet.

How Segluromet works

Ertugliflozin works by blocking the SGLT2 protein in your kidneys. This causes blood sugar to be removed in your urine.
Metformin works by inhibiting sugar (glucose) production in the liver.

What is type 2 diabetes?

Type 2 diabetes is a condition in which your body does not make enough insulin or the insulin that your body produces does not work as well as it should. Your body can also make too much sugar. When this happens, sugar (glucose) builds up in the blood. This can lead to serious medical problems, like heart disease, kidney disease, blindness and poor circulation.

2. what you need to know before you take segluromet

Do not take Segluromet

if you are allergic to ertugliflozin or metformin or any of the other ingredients of this medicine (listed in section 6).
if you have severely reduced kidney function or need dialysis.
if you have uncontrolled diabetes, with, for example, severe hyperglycaemia (high blood glucose), nausea, vomiting, diarrhoea, rapid weight loss, lactic acidosis (see “Risk of lactic acidosis” below) or ketoacidosis. Ketoacidosis is a condition in which substances called ‘ketone bodies’ accumulate in the blood and which can lead to diabetic pre-coma. Symptoms include stomach pain, fast and deep breathing, sleepiness, or your breath developing an unusual fruity smell.
if you have a severe infection or are dehydrated.
if you have recently had a heart attack or have severe circulatory problems, such as ‘shock’ or breathing difficulties.
if you have liver problems.
if you drink alcohol to excess (either regularly or from time to time).

Do not take Segluromet if any of the above apply to you. If you are not sure, talk to your doctor before taking Segluromet.

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before and while taking Segluromet, if you:

have kidney problems.
have or have had yeast infections of the vagina or penis.
have ever had serious heart disease or if you have had a stroke.
have type 1 diabetes. Segluromet should not be used to treat this condition.
take other diabetes medicines; you are more likely to get low blood sugar with certain

medicines.

might be at risk of dehydration (for example, if you are taking medicines that increase urine production [diuretics] lower blood pressure or if you are over 65 years old). Ask about ways to prevent dehydration.
experience rapid weight loss, feeling sick or being sick, stomach pain, excessive thirst, fast and deep breathing, confusion, unusual sleepiness or tiredness, a sweet smell to your breath, a sweet or metallic taste in your mouth or a different odour to your urine or sweat, contact a doctor or the nearest hospital straight away. These symptoms could be a sign of “diabetic ketoacidosis” -a problem you can get with diabetes because of increased levels of “ketone bodies” in your urine or blood, seen in tests. The risk of developing diabetic ketoacidosis may be increased with prolonged fasting, excessive alcohol consumption, dehydration, sudden reductions in insulin dose, or a higher need of insulin due to major surgery or serious illness.
have had a lower limb amputation.

It is important to check your feet regularly and adhere to any other advice regarding foot care and adequate hydration given by your healthcare professional. You should notify your doctor immediately if you notice any wounds or discolouration, or if you experience any tenderness or pain in your feet. Some studies indicate that taking ertugliflozin may have contributed to an increase in cases of lower limb amputation (mainly of the toe).

Talk to your doctor immediately if you develop a combination of symptoms of pain, tenderness, redness, or swelling of the genitals or the area between the genitals and the anus with fever or feeling generally unwell. These symptoms could be a sign of a rare but serious or even life-threatening infection, called necrotising fasciitis of the perineum or Fournier’s gangrene which destroys the tissue under the skin. Fournier’s gangrene has to be treated immediately.

When this medicine is used in combination with insulin or medicines that increase insulin release from the pancreas, low blood sugar (hypoglycaemia) can occur. Your doctor may reduce the dose of your insulin or other medicine.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Risk of lactic acidosis

Segluromet may cause a very rare, but very serious side effect called lactic acidosis, particularly if your kidneys are not working properly. The risk of developing lactic acidosis is also increased with uncontrolled diabetes, serious infections, prolonged fasting or alcohol intake, dehydration (see further information below), liver problems and any medical conditions in which a part of the body has a reduced supply of oxygen (such as acute severe heart disease).

If any of the above apply to you, talk to your doctor for further instructions.

Stop taking Segluromet for a short time if you have a condition that may be associated with dehydration (significant loss of body fluids) such as severe vomiting, diarrhoea, fever, exposure to heat or if you drink less fluid than normal. Talk to your doctor for further instructions.

Stop taking Segluromet and contact a doctor or the nearest hospital immediately if you experience some of the symptoms of lactic acidosis , as this condition may lead to coma.

Symptoms of lactic acidosis include:

vomiting
stomach ache (abdominal pain)
muscle cramps
a general feeling of not being well with severe tiredness
difficulty in breathing
reduced body temperature and heartbeat

Lactic acidosis is a medical emergency and must be treated in a hospital.

If you need to have major surgery you must stop taking Segluromet during and for some time after the procedure. Your doctor will decide when you must stop and when to restart your treatment with Segluromet.

During treatment with Segluromet, your doctor will check your kidney function at least once a year or more frequently if you are elderly and/or if you have worsening kidney function.

Urine glucose

Because of how Segluromet works, your urine will test positive for sugar (glucose) while you are on this medicine.

Children and adolescents

Children and adolescents below 18 years should not take this medicine. It is not known if this medicine is safe and effective when used in children and adolescents under 18 years of age.

Other medicines and Segluromet

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

You may need more frequent blood glucose and kidney function tests, or your doctor may need to adjust the dose of Segluromet. In particular, tell your doctor:

if you are taking medicines which increase urine production (diuretics).
if you are taking other medicines that lower the sugar in your blood, such as insulin or

medicines that increase insulin release from the pancreas.

if you are taking medicines used to treat pain and inflammation (NSAID and COX-2-inhibitors, such as ibuprofen and celecoxib).
if you are taking certain medicines for the treatment of high blood pressure (ACE inhibitors and angiotensin II receptor antagonists).

If any of the above apply to you (or you are not sure), tell your doctor.

If you need to have an injection of a contrast medium that contains iodine into your bloodstream, for example, in the context of an X-ray or scan, you must stop taking Segluromet before or at the time of the injection. Your doctor will decide when you must stop and when to restart your treatment with Segluromet.

Segluromet with alcohol

Avoid excessive alcohol intake while taking Segluromet since this may increase the risk of lactic acidosis (see section “Warnings and precautions”).

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

It is not known if Segluromet can harm your unborn baby. If you are pregnant, talk with your doctor about the best way to control your blood sugar while you are pregnant. You should not use Segluromet if you are pregnant.

It is not known if Segluromet passes into breast milk. Talk with your doctor about the best way to feed your baby if you take this medicine. You should not use Segluromet if you are breast-feeding.

Driving and using machines

This medicine has no or negligible influence on the ability to drive and use machines. Taking this medicine in combination with insulin or medicines that increase insulin release from the pancreas can cause blood sugar levels to drop too low (hypoglycaemia), which may cause symptoms such as shaking, sweating and change in vision, and may affect your ability to drive and use machines. Do not drive or use any tools or machines if you feel dizzy while taking Segluromet.

Segluromet contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. how to take segluromet

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

How much to take

The recommended dose of Segluromet is one tablet twice a day.
The dose of Segluromet that you take will depend on your condition and the amount of ertugliflozin and metformin needed to control your blood sugar.
Your doctor will prescribe the right dose for you. Do not change your dose unless your doctor has told you to.

Taking this medicine

Swallow the tablet; if you have difficulties in swallowing the tablet can be broken or crushed.
Take one tablet twice daily. Try to take it at the same time each day; this will help you

remember to take it.

It is best to take your tablet with a meal. This will lower your chance of having an upset stomach.
You need to keep following your food and exercise plan while taking Segluromet.

If you take more Segluromet than you should

If you take too much Segluromet, talk to a doctor or pharmacist straight away.

If you forget to take Segluromet

If you forget a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and go back to your regular schedule.

Do not take a double dose (two doses at the same time) to make up for a forgotten dose.

If you stop taking Segluromet

Do not stop taking this medicine without talking to your doctor. Your blood sugar levels may increase if you stop the medicine.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.

4. possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Contact a doctor or the nearest hospital straight away if you have any of the following serious side effects:

Lactic acidosis (very rare, may affect up to 1 in 10,000 people)

Segluromet may cause a very rare, but very serious side effect called lactic acidosis (see section “Warnings and precautions”). If this happens, you must stop taking Segluromet and contact a doctor or the nearest hospital immediately, as lactic acidosis may lead to coma.

Diabetic ketoacidosis (rare, may affect up to 1 in 1,000 people)

These are the signs of diabetic ketoacidosis (see also section “Warnings and precautions”):

increased levels of “ketone bodies” in your urine or blood
rapid weight loss
feeling sick or being sick
stomach pain
excessive thirst
fast and deep breathing
confusion
unusual sleepiness or tiredness
a sweet smell to your breath, a sweet or metallic taste in your mouth or a different odour to your

urine or sweat

This may occur regardless of blood glucose level. Your doctor may decide to temporarily or permanently stop your treatment with Segluromet.

Necrotising fasciitis of the perineum or Fournier’s gangrene (not known, cannot be estimated from the available data)

A serious soft tissue infection of the genitals or the area between the genitals and the anus (see section “Warnings and precautions” for symptoms).

If you notice any of the side effects above, contact a doctor or the nearest hospital straight away.

Contact your doctor as soon as possible if you notice the following side effects:

Dehydration (losing too much water from your body; common, may affect up to 1 in 10 people)

Symptoms of dehydration include:

dry mouth
feeling dizzy, light-headed, or weak, especially when you stand up
fainting

You may be more likely to get dehydrated if you:

have kidney problems
take medicines that increase your urine production (diuretics) or lower blood pressure
are 65 years or older

Low blood sugar (hypoglycaemia; common)

Your doctor will tell you how to treat low blood sugar and what to do if you have any of the symptoms or signs below. The doctor may lower the dose of your insulin or other diabetes medicine.

Signs and symptoms of low blood sugar may include:

headache
drowsiness
irritability
hunger
dizziness
confusion
sweating
feeling jittery
weakness
fast heart beat

If you notice any of the side effects above, contact your doctor as soon as possible.

Other side effects include:

Very common

vaginal yeast infection (thrush)
feeling sick (nausea)
vomiting
diarrhoea
stomach ache
loss of appetite

Common

yeast infections of the penis
changes in urination, including urgent need to urinate more often, in larger amounts, or at night
thirst
vaginal itching
change in taste
blood tests may show changes in the amount of urea in your blood
blood tests may show changes in the amount of total and bad cholesterol (called LDL – a type of

fat in your blood)

blood tests may show changes in the amount of red blood cells in your blood (called haemoglobin)

Uncommon (may affect up to 1 in 100 people)

blood tests may show changes related to kidney function (such as ‘creatinine’)
painful urination

Very rare

decreased vitamin B12 levels. This may cause anaemia (low levels of red blood cells).
liver function test disorders
hepatitis (a liver problem)
hives
redness of the skin
itching

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. how to store segluromet

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the blister and the carton after EXP.

The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not use this medicine if the packaging is damaged or shows signs of tampering.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. contents of the pack and other information

What Segluromet contains

The active substances are ertugliflozin and metformin.

o Each Segluromet 2.5 mg/850 mg film-coated tablet contains 2.5 mg ertugliflozin (as ertugliflozin L-pyroglutamic acid) and 850 mg of metformin hydrochloride.

o Each Segluromet 2.5 mg/1,000 mg film-coated tablet contains 2.5 mg ertugliflozin (as ertugliflozin L-pyroglutamic acid) and 1,000 mg of metformin hydrochloride.

o Each Segluromet 7.5 mg/850 mg film-coated tablet contains 7.5 mg ertugliflozin (as ertugliflozin L-pyroglutamic acid) and 850 mg of metformin hydrochloride.

o Each Segluromet 7.5 mg/1,000 mg film-coated tablet contains 7.5 mg ertugliflozin (as ertugliflozin L-pyroglutamic acid) and 1,000 mg of metformin hydrochloride.

The other ingredients are:

o Tablet core: povidone (K29–32) (E1201), microcrystalline cellulose (E460), crospovidone (E1202), sodium lauryl sulfate (E487), magnesium stearate (E470b).

Film coating:

o Segluromet 2.5 mg/850 mg tablets and Segluromet 7.5 mg/850 mg tablets: hypromellose (E464), hydroxypropyl cellulose (E463), titanium dioxide (E171), iron oxide red (E172), iron oxide yellow (E172), iron oxide black (E172), carnauba wax (E903).

o Segluromet 2.5 mg/1,000 mg tablets and Segluromet 7.5 mg/1,000 mg tablets: hypromellose (E464), hydroxypropyl cellulose (E463), titanium dioxide (E171), iron oxide red (E172), carnauba wax (E903).

What Segluromet looks like and contents of the pack

Segluromet 2.5 mg/850 mg film-coated tablets (tablets) are beige, 18 × 10 mm oval, film-coated tablets debossed with “2.5/850” on one side and plain on the other side.
Segluromet 2.5 mg/1,000 mg film-coated tablets (tablets) are pink, 19.1 × 10.6 mm oval,

film-coated tablets debossed with “2.5/1000” on one side and plain on the other side.

Segluromet 7.5 mg/850 mg film-coated tablets (tablets) are dark brown, 18 × 10 mm oval, film-coated tablets debossed with “7.5/850” on one side and plain on the other side.
Segluromet 7.5 mg/1,000 mg film-coated tablets (tablets) are red, 19.1 × 10.6 mm oval,

This leaflet was last revised in February 2021.

PIL.SEG.20.UK.7487.CoO.RCN019491